MedPath

Prandin

PRANDIN(repaglinide) Tablets (0.5, 1, and 2 mg)

Approved
Approval ID

e2a07020-a596-4282-bb7c-c9ebe6edcd61

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Aug 6, 2016

Manufacturers
FDA

Carilion Materials Management

DUNS: 079239644

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

repaglinide

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code68151-3566
Application NumberNDA020741
Product Classification
M
Marketing Category
C73594
G
Generic Name
repaglinide
Product Specifications
Route of AdministrationORAL
Effective DateOctober 15, 2014
FDA Product Classification

INGREDIENTS (1)

REPAGLINIDEActive
Quantity: 1 mg in 1 1
Code: 668Z8C33LU
Classification: ACTIB

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Prandin - FDA Drug Approval Details